Clinical Breast Cancer是一本专注于乳腺癌研究的国际学术期刊，ISSN号为1526-8209，由美国出版商Elsevier出版，出版地为美国，出版周期为双月刊。该期刊的影响因子根据最新数据约为3.0左右，属于非开放获取（非OA）期刊，并被SCI收录，在中科院分区中通常位于医学类3区或4区。杂志的发文特点集中于乳腺癌的临床与转化研究，涵盖诊断、治疗、预后及分子机制等领域，尤其关注创新疗法和临床试验成果。其质量在乳腺癌领域具有一定影响力，但影响因子相对中等，可能存在投稿竞争激烈或审稿周期较长的风险，适合从事乳腺癌研究的临床医生和科研人员投稿。
Anesthetic Agents as Therapeutic Tools in Breast Cancer: Insights into Cancer Progression and Recurrence
2025-02-14T00:13:43Z
Does Undertreatment With Chemotherapy Impact the Outcomes of Elderly Patients With Early-Stage Breast Cancer? A Real-World Data Analysis
2025-02-19T00:20:01Z
Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study
2025-03-05T00:29:20Z
Characterizing Cannabidiol Use in a Breast Cancer Population
2025-02-07T08:15:10Z
Evaluation of Disease Severity, Respiratory Muscle Strength, Respiratory Functions, Functionality, and Quality of Life in Patients With Upper Limb Lymphedema
2025-01-25T16:09:14Z
In Triple-Negative Breast Cancer: Correlation Among Metabolic Syndrome, S100A7/cPLA2 Expression and the Efficacy of Neoadjuvant Chemotherapy
2025-02-28T07:59:53Z
Trends in Surgical Axillary Staging and Clinical Outcomes Among Breast Cancer Patients With Neoadjuvant Therapy: A Population-Based Cohort Study
2025-02-06T17:11:33Z
Relationship Between Chronic Pain and Breast Cancer: Insight From Genetic Correlation Analyses and 2-Sample Mendelian Randomization
2025-02-19T00:20:04Z
Forequarter Amputation for Breast Cancer. Systematic Review and Survival Analysis
2025-03-10T07:39:49Z
The Impact of the COVID-19 Pandemic on the Diagnosis and Treatment of Breast Cancer at a Community Hospital
2025-02-14T08:15:23Z
Tranexamic Acid in Breast Surgery – A Systematic Review and Meta-Analysis
2025-01-23T18:52:06Z
Enhancing the Assessment of Breast Cancer Surgery Information on YouTube
2025-02-20T23:37:12Z
Development of Machine Learning Models for Predicting Radiation Dermatitis in Breast Cancer Patients Using Clinical Risk Factors, Patient-Reported Outcomes, and Serum Cytokine Biomarkers
2025-03-05T17:08:33Z
Editorial Board
2025-06-16T15:53:44Z
Habitat-Based Radiomics for Revealing Tumor Heterogeneity and Predicting Residual Cancer Burden Classification in Breast Cancer
2025-02-04T16:33:54Z
Perioperative Considerations of Breast Cancer Neoadjuvant Treatments
2025-03-07T04:47:07Z
Harnessing Artificial Intelligence for Precision Diagnosis and Treatment of Triple Negative Breast Cancer
2025-03-08T21:23:23Z
Evaluation of Neutrophil Activation Biomarkers in Response to Programmed Cell Death Protein-1 (PD-1) and Toll-like Receptor 9 (TLR-9) Inhibition in Triple Negative Breast Cancer
2025-01-31T16:51:34Z
